Development of antibody drug conjugates for cancer therapy
Antibody Drug Conjugates (ADC), are biopharmaceutical drugs that are used in cancer treatment. It comprises of an antibody portion that targets the cancer cells and a conjugated cytotoxic drug to kill them. This project aims to develop a novel approach towards ADC production by utilizing Butelase1 (...
Saved in:
Main Author: | Alif Sufiyan Ali |
---|---|
Other Authors: | Liu Chuan Fa |
Format: | Final Year Project |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/74400 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Recent developments in chemical conjugation strategies targeting native amino acids in proteins and their applications in antibody-drug conjugates
by: Kang, Min Sun, et al.
Published: (2023) -
Delivery of siRNA using novel conjugates for cancer therapy.
by: Guo, Venetia Yixin.
Published: (2010) -
Innovative Design of Targeted Nanoparticles: Polymer–Drug Conjugates for Enhanced Cancer Therapy
by: Junyaprasert V.B.
Published: (2023) -
Use of peptide asparginyl ligases (PALs) in generating alternative non-Ig protein-drug conjugates for cancer therapy
by: See, Julia Jing Yi
Published: (2023) -
Immunodiagnosis for cervical cancer using antibody-gold nanoparticle conjugate
by: S. Tapaneeyakorn, et al.
Published: (2018)